Industries BiotechnologyMedicalTherapeuticsHeadquarters Regions Europe, Middle East, and Africa (EMEA) Founded Date 1997 Founders Hugh Griffith Operating Status Active Last Funding Type Post-IPO Equity Legal Name NuCana PLC
Stock Symbol NASDAQ:NCNA Company Type For Profit
Contact Email info@nucanabiomed.com Phone Number 44 13 1248 3660
NuCana BioMed is an emerging biopharmaceutical company dedicated to the discovery, development and commercialisation of innovative, rationally designed medicines that address significant unmet medical needs.
Our management team has extensive experience of building successful biopharmaceutical companies. This includes the formation and subsequent
growth of Bioenvision into a NASDAQ National listed, global biopharmaceutical company, which was acquired by Genzyme Corporation in October 2007. Specific management expertise includes the development, approval and commercialisation of oncology medicines.
We are developing a portfolio of first-in-class and best-in-class pharmaceutical products designed to treat life-threatening or debilitating diseases. Our primary focus is in the area of oncology, although our technology platform has broader clinical potential.